Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G for TENAX THERAPEUTICS, INC. Common Stock (TENX).
- Disclosed ownership: 9.6%.
- Date of event: 31 Dec 2025.
MORGAN STANLEY - 31 Dec 2025 SCHEDULE 13G Report for TENAX THERAPEUTICS, INC. Common Stock (TENX)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- TENX
- Shares outstanding
- 6,212,250 shares
- Disclosed Ownership
- 596,376 shares
- Ownership
- 9.6%
- Form type
- SCHEDULE 13G
- Filing time
- 12 Feb 2026, 13:21:10 UTC
- Date of event
- 31 Dec 2025
- Next filing
- 08 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 9.6% ownership in TENAX THERAPEUTICS, INC. Common Stock (TENX) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2026, 13:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 9.6% | 596,376 | 0 | 592,316 | Chris O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Capital Services LLC | 9.5% | 592,316 | 0 | 592,316 | Chris O'Hara | Authorized Signatory, Morgan Stanley Capital Services LLC |